Clinical Trial Detail

NCT ID NCT03008187
Title SEL24 in Patients With AML
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Selvita S.A.
Indications

acute myeloid leukemia

Therapies

SEL24-B489

Age Groups: senior adult

No variant requirements are available.